Wellstar International, Inc. Announces Appointments to Medical Advisory Board
18 Septiembre 2008 - 9:15AM
Marketwired
Wellstar International, Inc. (OTCBB: WLSI), a developer of thermal
imaging, diagnostic software and equipment, announced today that it
has made key additions to its medical advisory board as of
September 2008. Leonard Makowka, MD, PhD, a distinguished clinical
surgeon, transplantation specialist and medical researcher, Michael
Shen, MD, an internal medicine specialist and expert in
cardiovascular disease, and Courtney H. Lyder, ND, a professor of
nursing and current Dean of Nursing at University of California,
Los Angeles, will all serve as advisors to management and the board
of directors, as Wellstar rolls out its revolutionary thermal
imaging technologies to additional hospitals in the U.S. and
worldwide. Dr. Shen is currently a member of the Company's board of
directors, and plans to continue in that capacity in addition to
his new advisory role.
Current shareholders and interested investors seeking additional
biographical/background information on these newly appointed
advisors should visit Wellstar International's corporate Website at
www.wellstar.us. Curriculum vitae for all three can be downloaded
in PDF format. A short, summary biography of each advisor is listed
below:
Leonard Makowka, M.D., Ph.D., F.R.C.S.(C.), F.A.C.S.
With over twenty-three years experience as a research physician
and medical doctor, Dr. Leonard Makowka is well known for his
prolific, scientific research on organ regeneration and
transplantation, and as a leader in the field of hepatic science
(relating to the liver). In 1989, Dr. Makowka was the youngest
doctor ever to be appointed as Chairman of the Department of
Surgery of Cedars-Sinai Medical Center in Los Angeles. He has been
published over 350 times in various respected medical journals, and
has received over $9 million in grants for his research on organ
transplants. In addition to being an accomplished surgeon and
research physician, Dr. Makowka is also an adept businessman and
entrepreneur, who has founded and/or co-founded several very
successful business enterprises.
Michael Y.H. Shen, M.D., M.S., F.A.C.C.
With twenty years experience as a medical doctor in the U.S.,
Dr. Shen originally earned his medical doctorate at Jiamusi College
in P.R. China. Dr. Shen is an expert in the field of cardiology,
cardiac imaging, and in the more recently prioritized arena of
health care information management. He has spent much of his career
as a practicing physician specializing in internal medicine and
cardiovascular health. His many faculty appointments, committees
that he serves on, and his many articles published in medical
journals are all mostly focused on nuclear cardiology and
cardiovascular science. Dr. Shen will be able to provide continued,
valuable support to Wellstar for the Company's ambitions of
entering the Chinese hospital/health care market.
Courtney Lyder, N.D., M.S., C.W.S., R.N.
Dr. Courtney Lyder (PhD in nursing) brings to Wellstar a
tremendous background in wound care, hospital operations and nurse
care management. Dr. Lyder currently serves as the Dean of Nursing
at the University of California, Los Angeles (UCLA), and is widely
respected by his peers as the preeminent expert in treating the
elderly, and wounds caused by inactivity. Dr. Lyder holds
specialized certifications as a gerontological nurse practitioner
and as a certified wound specialist. He has been a licensed RN
since 1989. His advisory role for Wellstar will be extremely
important as the Company expands its client base and further
develops its imaging products and service offerings.
In addition to visiting Wellstar's corporate Website, interested
investors seeking further information are encouraged to call the
Company's investor relations' representatives, toll-free, at (800)
953-3350.
ABOUT WELLSTAR INTERNATIONAL, INC.:
Wellstar International, Inc., through its wholly owned operating
subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the health care industry.
TMI has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website, by
visiting: www.wellstar.us.
FORWARD-LOOKING STATEMENTS:
This press release contains statements, which may constitute
'forward-looking statements' within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual
results to differ materially from those in forward-statements
include fluctuation of operating results, the ability to compete
successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
CONTACT: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free,
U.S. & Canada (858) 436-3350 Local or International 9:30 a.m.
to 5:00 p.m. Daily
Wellstar (CE) (USOTC:WLSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Wellstar (CE) (USOTC:WLSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024